Sheela Harinath, Seela Srinivas, Caldwell Cary, Boyer James L, Jain Dhanpat
Department of Internal Medicine, Section of Digestive Diseases and Liver Center, Yale University School of Medicine, New Haven, CT 06510, USA.
J Clin Gastroenterol. 2005 Aug;39(7):603-10. doi: 10.1097/01.mcg.0000170742.59134.60.
Since the origination of the liver biopsy, the technique has evolved into an essential diagnostic tool, with very few complications. In addition to the percutaneous approach, a liver biopsy can also be obtained via transjugular, laparoscopic, or intraoperative approach. While in the early 1960s and 1970s the liver biopsy was used for making a diagnosis in cases of clinically suspected medical liver disease, today it is more often performed to assess disease prognosis and evaluate therapeutic strategies. As a result, indications for the liver biopsy have evolved over the past 2 decades. However with advances in serologic diagnosis of viral/autoimmune hepatitis and laboratory tests for genetic disorders, the role of liver biopsy in certain clinical settings is currently debated. This review discusses the technique, indications, contraindications, and the changing role of liver biopsy in some of the common disorders and the associated controversies.
自肝脏活检技术问世以来,该技术已发展成为一种基本的诊断工具,并发症极少。除经皮穿刺途径外,肝脏活检还可通过经颈静脉、腹腔镜或术中途径获取。在20世纪60年代和70年代早期,肝脏活检用于对临床疑似的内科性肝病进行诊断,而如今则更多地用于评估疾病预后和评价治疗策略。因此,肝脏活检的适应证在过去20年中发生了演变。然而,随着病毒/自身免疫性肝炎血清学诊断以及遗传性疾病实验室检测技术的进步,肝脏活检在某些临床情况下的作用目前存在争议。本综述讨论了肝脏活检的技术、适应证、禁忌证,以及其在一些常见疾病中的作用变化和相关争议。